PHARMACOVIGILANCE: WHERE DO WE STAND?

Pharmacovigilance is a system, not only significant to the early detection of adverse drug reactions; but also facilitates identification of risk in post marketing period. Contribution to Uppsala monitoring database from developing countries including India is still negligible due to the poor reporting culture, lack of knowledge in healthcare professionals regarding pharmacovigilance etc. are so many reason which are barrier for emerging this essential department in pharmaceutical industry. This article aims at bringing such issues into notice with respect to pharmacovigilance systems and look upon some measures that may be taken to safeguard the patients who take the drug for their better health, not for suffering the toxic effects, also some suggestion to improvising the health standards